Background: A gap remains between evidence-based guidelines in the treatment of heart failure and current pharmacologic and device therapy. The reasons for this are multiple, including the failure to recognize the benefit of increased therapeutic intervention in an otherwise stable patient. The Seattle Heart Failure Model is an accurate predictive tool that allows the clinician to quantitatively assess the influence of pharmacologic and device therapy on heart failure. We hypothesized that graphically demonstrating the improvement in survival by such a tool may well modify physician practice behavior.
